Free Trial
TSE:CPH

Cipher Pharmaceuticals (CPH) Stock Price, News & Analysis

Cipher Pharmaceuticals logo
C$13.29 -0.28 (-2.06%)
As of 07/7/2025 04:00 PM Eastern

About Cipher Pharmaceuticals Stock (TSE:CPH)

Key Stats

Today's Range
C$13.11
C$13.50
50-Day Range
C$12.10
C$14.56
52-Week Range
C$8.18
C$19.69
Volume
23,933 shs
Average Volume
30,079 shs
Market Capitalization
C$238.60 million
P/E Ratio
14.68
Dividend Yield
N/A
Price Target
C$14.75
Consensus Rating
Moderate Buy

Company Overview

Receive CPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cipher Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

CPH Stock News Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More Headlines

CPH Stock Analysis - Frequently Asked Questions

Cipher Pharmaceuticals' stock was trading at C$14.32 at the start of the year. Since then, CPH stock has decreased by 7.2% and is now trading at C$13.29.

Cipher Pharmaceuticals Inc. (TSE:CPH) announced its earnings results on Thursday, August, 10th. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.15 by $0.01. The company had revenue of $7.10 million for the quarter, compared to the consensus estimate of $7.46 million. Cipher Pharmaceuticals had a net margin of 59.92% and a trailing twelve-month return on equity of 17.93%.
Read the conference call transcript
.

Shares of CPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cipher Pharmaceuticals investors own include Cipher Pharmaceuticals (CPHRF), Enbridge (ENB), Bellatrix Exploration (BXE), Crescent Point Energy (CPG), Manulife Financial (MFC), Surge Energy (SGY) and Toronto-Dominion Bank (TD).

Company Calendar

Last Earnings
8/10/2023
Today
7/07/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
TSE:CPH
Previous Symbol
TSE:DND
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$14.75
High Stock Price Target
C$17.00
Low Stock Price Target
C$12.50
Potential Upside/Downside
+11.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
14.68
Forward P/E Ratio
10.30
P/E Growth
N/A
Net Income
C$11.41 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$19.03 million
Cash Flow
C$3.77 per share
Price / Cash Flow
3.53
Book Value
C$3.96 per share
Price / Book
3.36

Miscellaneous

Free Float
N/A
Market Cap
C$238.60 million
Optionable
Not Optionable
Beta
1.20
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (TSE:CPH) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners